Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc. AMPE

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.


Recent & Breaking News (NYSEAM:AMPE)

Ampio Deadline Alert

Newsfile 10 hours ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

Newsfile 1 day ago

Ampio Deadline Alert

Newsfile 2 days ago

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

PR Newswire 2 days ago

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

PR Newswire 2 days ago

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 17, 2022 in Ampio Lawsuit - AMPE

Newsfile 2 days ago

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire 3 days ago

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

PR Newswire 4 days ago

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile 4 days ago

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

PR Newswire 4 days ago

Ampio Deadline Alert

Newsfile 6 days ago

Ampio Deadline Alert

Newsfile 7 days ago

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

Newsfile 8 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

Newsfile 8 days ago

Ampio Deadline Alert

Newsfile 9 days ago

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

PR Newswire 9 days ago

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

Newsfile 9 days ago

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

PR Newswire 10 days ago

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire 10 days ago

Ampio Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 17, 2022 to Discuss Your Rights - AMPE

Newsfile 10 days ago